Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis. (Q38139191)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048085%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048085%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

1 reference

Janice M Leung

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048085%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Kenneth N Olivier

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048085%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

1 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048085%20AND%20SRC:MED&resulttype=core&format=json

Current Opinion in Pulmonary Medicine

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048085%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048085%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048085%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

662-669

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048085%20AND%20SRC:MED&resulttype=core&format=json

Risk-benefit assessment of therapies for Mycobacterium avium complex infections

22 February 2020

cites work

1 reference

12 December 2020

Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease

1 reference

12 December 2020

Eradication of mycobacterium abscessus in a chronically infected patient with cystic fibrosis

1 reference

12 December 2020

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

1 reference

12 December 2020

Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis

1 reference

12 December 2020

Nontuberculous mycobacteria in patients with cystic fibrosis

1 reference

12 December 2020

Lack of transmission of mycobacterium abscessus among patients with cystic fibrosis attending a single clinic

1 reference

12 December 2020

Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis

1 reference

12 December 2020

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

1 reference

12 December 2020

Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.

1 reference

12 December 2020

Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease.

1 reference

12 December 2020

In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria

1 reference

12 December 2020

Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.

1 reference

12 December 2020

Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis

1 reference

12 December 2020

Prospective study on nontuberculous mycobacteria in patients with and without cystic fibrosis.

1 reference

12 December 2020

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

1 reference

12 December 2020

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

1 reference

12 December 2020

Mycobacterium abscessus and children with cystic fibrosis

1 reference

12 December 2020

Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii.

1 reference

12 December 2020

Amoebal coculture of "Mycobacterium massiliense" sp. nov. from the sputum of a patient with hemoptoic pneumonia

1 reference

12 December 2020

Late diagnosis defines a unique population of long-term survivors of cystic fibrosis

1 reference

12 December 2020

Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy

1 reference

12 December 2020

Nontuberculous mycobacterial infection in young children with cystic fibrosis

1 reference

12 December 2020

1 reference

12 December 2020

Nontuberculous mycobacteria in cystic fibrosis

1 reference

12 December 2020

Nontuberculous Mycobacteria in Adult Patients with Cystic Fibrosis

1 reference

12 December 2020

rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov

1 reference

12 December 2020

Adult cystic fibrosis presenting with recurrent non-tuberculous mycobacterial infections

1 reference

12 December 2020

Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient

1 reference

12 December 2020

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

1 reference

12 December 2020

Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series

1 reference

12 December 2020

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

1 reference

12 December 2020

Lung resection in cystic fibrosis: a survival analysis

1 reference

12 December 2020

Activities of Linezolid against nontuberculous mycobacteria.

1 reference

12 December 2020

Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel

1 reference

12 December 2020

Surgical treatment of pulmonary diseases due to nontuberculous mycobacteria

1 reference

12 December 2020

Acute respiratory failure involving an R variant of Mycobacterium abscessus

1 reference

12 December 2020

Nontuberculous mycobacterial infection in patients with cystic fibrosis: a multicenter prevalence study

1 reference

12 December 2020

Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment

1 reference

12 December 2020

Mycobacterium abscessus in cystic fibrosis lung transplant recipients: report of 2 cases and risk for recurrence

1 reference

12 December 2020

Predicting outcome following pulmonary resection in cystic fibrosis patients

1 reference

12 December 2020

Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.

1 reference

12 December 2020

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985-2005.

1 reference

12 December 2020

Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors

1 reference

12 December 2020

Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france

1 reference

12 December 2020

Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis

1 reference

12 December 2020

Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection

1 reference

12 December 2020

Aerosolized amikacin and oral clarithromycin to eradicate Mycobacterium abscessus in a patient with cystic fibrosis: an 8-year follow-up

1 reference

12 December 2020

Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns

1 reference

12 December 2020

Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus

1 reference

12 December 2020

Assessment of infection risks prior to lung transplantation

1 reference

12 December 2020

Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France

1 reference

12 December 2020

Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing

1 reference

12 December 2020

Lady Windermere revisited: treatment with thoracoscopic lobectomy/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease.

1 reference

12 December 2020

Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007.

1 reference

12 December 2020

Mycobacterial infections in a large Virginia hospital, 2001-2009.

1 reference

12 December 2020

Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection.

1 reference

12 December 2020

Changes in cystic fibrosis mortality in Australia, 1979-2005.

1 reference

12 December 2020

Clofazimine: current status and future prospects

1 reference

12 December 2020

Evaluation of infections in the lung transplant patient

1 reference

12 December 2020

Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center

1 reference

12 December 2020

Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case–control study

1 reference

12 December 2020

Thoracoscopic lobectomy and segmentectomy for infectious lung disease

1 reference

12 December 2020

Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance

1 reference

12 December 2020

Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases.

1 reference

12 December 2020

Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients

1 reference

12 December 2020

Genomic insights into the emerging human pathogen Mycobacterium massiliense

1 reference

12 December 2020

Macrolide antibiotics for cystic fibrosis

1 reference

12 December 2020

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis

1 reference

12 December 2020

Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study

1 reference

12 December 2020

Prospective study of mycobacterial infections in patients with cystic fibrosis

1 reference

12 December 2020

Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis

1 reference

12 December 2020

Mycobacterium avium complex in a patient with cystic fibrosis: disease vs. colonization

1 reference

12 December 2020

Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance

1 reference

12 December 2020

Pulmonary resection for localized bronchiectasis in cystic fibrosis. Report of three cases and review of the literature

1 reference

12 December 2020

Introduction to pharmacokinetics: aminoglycosides in cystic fibrosis as a prototype

1 reference

12 December 2020

Bacterial Flora of Respiratory Tract in Patients with Cystic Fibrosis, 1950-1971

1 reference

12 December 2020

Pulmonary Resection for Life-Threatening Hemoptysis in Cystic Fibrosis

1 reference

12 December 2020

Mycobacterial isolations in young adults with cystic fibrosis

1 reference

12 December 2020

Pulmonary resection for complications of cystic fibrosis

1 reference

12 December 2020

Fatal pulmonary infection with Mycobacterium fortuitum in cystic fibrosis.

1 reference

12 December 2020

Isolation of rapidly growing mycobacteria in patients with cystic fibrosis

1 reference

12 December 2020

The role of Mycobacteria Other Than Tuberculosis (MOTT) in patients with cystic fibrosis

1 reference

12 December 2020

Nontuberculous mycobacterial disease in adult cystic fibrosis patients

1 reference

12 December 2020

Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis

1 reference

12 December 2020

Lung resection in cystic fibrosis patients with localised pulmonary disease

1 reference

12 December 2020

Pulmonary disease caused by Mycobacterium kansasii in a patient with cystic fibrosis

1 reference

12 December 2020

Mycobacterial lung disease in cystic fibrosis: a prospective study

1 reference

12 December 2020

Non-tuberculous mycobacteria in cystic fibrosis

1 reference

12 December 2020

Results of operation in Mycobacterium avium-intracellulare lung disease

1 reference

12 December 2020

Drug disposition in cystic fibrosis

1 reference

12 December 2020

10.1097/MCP.0B013E328365AB33

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048085%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24048085%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference